155 related articles for article (PubMed ID: 31346562)
1. Profilin 1 Negatively Regulates Osteoclast Migration in Postnatal Skeletal Growth, Remodeling, and Homeostasis in Mice.
Shirakawa J; Kajikawa S; Böttcher RT; Costell M; Izu Y; Hayata T; Noda M; Ezura Y
JBMR Plus; 2019 Jun; 3(6):e10130. PubMed ID: 31346562
[TBL] [Abstract][Full Text] [Related]
2. Profilin-1 negatively controls osteoclast migration by suppressing the protrusive structures based on branched actin filaments.
Kajikawa S; Ezura Y; Izu Y; Nakashima K; Noda M; Nifuji A
J Bone Miner Metab; 2022 Jul; 40(4):561-570. PubMed ID: 35428898
[TBL] [Abstract][Full Text] [Related]
3. Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget's Disease of Bone with
Ling Z; Aini H; Kajikawa S; Shirakawa J; Tsuji K; Asou Y; Koga H; Sekiya I; Nifuji A; Noda M; Ezura Y
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895866
[TBL] [Abstract][Full Text] [Related]
4. Profilin1 regulates sternum development and endochondral bone formation.
Miyajima D; Hayata T; Suzuki T; Hemmi H; Nakamoto T; Notomi T; Amagasa T; Böttcher RT; Costell M; Fässler R; Ezura Y; Noda M
J Biol Chem; 2012 Sep; 287(40):33545-53. PubMed ID: 22773831
[TBL] [Abstract][Full Text] [Related]
5. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
[TBL] [Abstract][Full Text] [Related]
6. Profilin Expression Is Regulated by Bone Morphogenetic Protein (BMP) in Osteoblastic Cells.
Lin W; Ezura Y; Izu Y; Aryal SA; Kawasaki M; Chantida PN; Moriyama K; Noda M
J Cell Biochem; 2016 Mar; 117(3):621-8. PubMed ID: 26271366
[TBL] [Abstract][Full Text] [Related]
7. SMAD1/5 signaling in osteoclasts regulates bone formation via coupling factors.
Tasca A; Astleford K; Blixt NC; Jensen ED; Gopalakrishnan R; Mansky KC
PLoS One; 2018; 13(9):e0203404. PubMed ID: 30188920
[TBL] [Abstract][Full Text] [Related]
8. Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease.
Merlotti D; Materozzi M; Bianciardi S; Guarnieri V; Rendina D; Volterrani L; Bellan C; Mingiano C; Picchioni T; Frosali A; Orfanelli U; Cenci S; Gennari L
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32392277
[TBL] [Abstract][Full Text] [Related]
9. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
10. Conditional Disruption of
Lau KW; Stiffel VM; Rundle CH; Amoui M; Tapia J; White TD; Sheng MH
JBMR Plus; 2017 Oct; 1(2):73-85. PubMed ID: 29082358
[TBL] [Abstract][Full Text] [Related]
11. NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover.
Scholtysek C; Ipseiz N; Böhm C; Krishnacoumar B; Stenzel M; Czerwinski T; Palumbo-Zerr K; Rothe T; Weidner D; Klej A; Stoll C; Distler J; Tuckermann J; Herrmann M; Fabry B; Goldmann WH; Schett G; Krönke G
J Bone Miner Res; 2018 Nov; 33(11):2035-2047. PubMed ID: 29949664
[TBL] [Abstract][Full Text] [Related]
12. Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF.
Nishino I; Amizuka N; Ozawa H
J Bone Miner Metab; 2001; 19(5):267-76. PubMed ID: 11498728
[TBL] [Abstract][Full Text] [Related]
13. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA
J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
[TBL] [Abstract][Full Text] [Related]
14. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
[TBL] [Abstract][Full Text] [Related]
15. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
17. Role of cytokines in the regulation of bone resorption.
Roodman GD
Calcif Tissue Int; 1993; 53 Suppl 1():S94-8. PubMed ID: 8275387
[TBL] [Abstract][Full Text] [Related]
18. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
19. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
